SEC Form 4 · accession 0001144204-18-016909
BRAINSTORM CELL THERAPEUTICS INC. · BCLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arturo Araya
Director
Period of report
Mar 26, 2018
Accepted (ET)
Mar 26, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137883
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 26, 2018 | A | 1,249 | $0.00 | A | 8,413 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired are shares of restricted stock awarded on March 26, 2018 pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan and the reporting person's election to the Governance, Nominating and Compensation Committee. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on April 26, 2018 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a member of the Governance, Nominating and Compensation Committee of the Board of Directors of Brainstorm Cell Therapeutics on each vesting date.